{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:37:05Z","timestamp":1794278225928,"version":"4.9.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research and Development Project of the Jilin Provincial Department of Science and Technology","award":["20220203153SF"],"award-info":[{"award-number":["20220203153SF"]}]},{"name":"Qihuang scholar in the National Support Program for Leading Talents of Traditional Chinese Medicine","award":["[2018] No. 12"],"award-info":[{"award-number":["[2018] No. 12"]}]},{"name":"Key Project of National Natural Science Foundation of China","award":["82130119"],"award-info":[{"award-number":["82130119"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77921-6","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:04:06Z","timestamp":1730297046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk of Alzheimer\u2019s disease and genetically predicted levels of 1400 plasma metabolites: a Mendelian randomization study"],"prefix":"10.1038","volume":"14","author":[{"given":"Di","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yini","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"77921_CR1","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/alz.12694","volume":"19","author":"A Gustavsson","year":"2023","unstructured":"Gustavsson, A. et al. Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimers Dement. 19, 658\u2013670 (2023).","journal-title":"Alzheimers Dement."},{"key":"77921_CR2","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.3390\/ijms24087258","volume":"24","author":"A Afsar","year":"2023","unstructured":"Afsar, A., Chacon Castro, M. D. C., Soladogun, A. S. & Zhang, L. Recent development in the understanding of molecular and cellular mechanisms underlying the etiopathogenesis of Alzheimer\u2019s disease. Int. J. Mol. Sci. 24, 7258 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"77921_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol. Neurodegener. 15, 40 (2020).","journal-title":"Mol. Neurodegener."},{"key":"77921_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane, S. C. et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat. Rev. Drug Discov. 19, 609\u2013633 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77921_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13195-019-0551-7","volume":"11","author":"V Van Der Velpen","year":"2019","unstructured":"Van Der Velpen, V. et al. Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease. Alzheimers Res. Ther. 11, 93 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"77921_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jalz.2019.03.004","volume":"15","author":"M Kim","year":"2019","unstructured":"Kim, M. et al. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer\u2019s disease biomarker discovery cohort. Alzheimers Dement. 15, 817\u2013827 (2019).","journal-title":"Alzheimers Dement."},{"key":"77921_CR7","doi-asserted-by":"publisher","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","volume":"15","author":"VR Varma","year":"2018","unstructured":"Varma, V. R. et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLoS Med. 15, e1002482 (2018).","journal-title":"PLoS Med."},{"key":"77921_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13195-023-01378-4","volume":"16","author":"J Zhu","year":"2024","unstructured":"Zhu, J. et al. Associations between genetically predicted plasma protein levels and Alzheimer\u2019s disease risk: a study using genetic prediction models. Alzheimers Res. Ther. 16, 8 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"77921_CR9","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P., Del Greco, M. F., Pattaro, C. & K\u00f6ttgen, A. Mendelian randomization as an approach to assess causality using observational data. J. Am. Soc. Nephrol. 27, 3253\u20133265 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"77921_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ije\/dyv108","volume":"44","author":"S Burgess","year":"2015","unstructured":"Burgess, S., Timpson, N. J., Ebrahim, S. & Davey Smith, G. Mendelian randomization: where are we now and where are we going? Int. J. Epidemiol. 44, 379\u2013388 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"77921_CR11","doi-asserted-by":"publisher","first-page":"a040501","DOI":"10.1101\/cshperspect.a040501","volume":"12","author":"RC Richmond","year":"2022","unstructured":"Richmond, R. C. & Davey Smith, G. Mendelian randomization: Concepts and scope. Cold Spring Harb. Perspect. Med. 12, a040501 (2022).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"77921_CR12","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89\u2013R98 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"77921_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/gepi.22295","volume":"44","author":"EAW Slob","year":"2020","unstructured":"Slob, E. A. W. & Burgess, S. A comparison of robust Mendelian randomization methods using summary data. Genet. Epidemiol. 44, 313\u2013329 (2020).","journal-title":"Genet. Epidemiol."},{"key":"77921_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3233\/JAD-230985","volume":"98","author":"M Zhai","year":"2024","unstructured":"Zhai, M. et al. Genetic insights into the association and causality between blood metabolites and Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 98, 885\u2013896 (2024).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"77921_CR15","doi-asserted-by":"publisher","first-page":"680104","DOI":"10.3389\/fnins.2021.680104","volume":"15","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. Assessing causal relationship between human blood metabolites and five neurodegenerative diseases with GWAS summary statistics. Front. Neurosci. 15, 680104 (2021).","journal-title":"Front. Neurosci."},{"key":"77921_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat. Genet. 55, 44\u201353 (2023).","journal-title":"Nat. Genet."},{"key":"77921_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s43094-024-00673-7","volume":"10","author":"MC Pedrazini","year":"2024","unstructured":"Pedrazini, M. C., Martinez, E. F., dos Santos, V. A. B. & Groppo, F. C. L-arginine: Its role in human physiology, in some diseases and mainly in viral multiplication as a narrative literature review. Future J. Pharm. Sci. 10, 99 (2024).","journal-title":"Future J. Pharm. Sci."},{"key":"77921_CR18","first-page":"211","volume":"2","author":"J Yi","year":"2009","unstructured":"Yi, J. et al. L-arginine and Alzheimer\u2019s disease. Int. J. Clin. Exp. Pathol. 2, 211\u2013238 (2009).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"77921_CR19","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","volume":"35","author":"P Liu","year":"2014","unstructured":"Liu, P. et al. Altered arginine metabolism in Alzheimer\u2019s disease brains. Neurobiol. Aging. 35, 1992\u20132003 (2014).","journal-title":"Neurobiol. Aging"},{"key":"77921_CR20","doi-asserted-by":"publisher","first-page":"759729","DOI":"10.3389\/fnmol.2021.759729","volume":"14","author":"SSA Mamsa","year":"2021","unstructured":"Mamsa, S. S. A. & Meloni, B. P. Arginine and arginine-rich peptides as modulators of protein aggregation and cytotoxicity associated with Alzheimer\u2019s disease. Front. Mol. Neurosci. 14, 759729 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"77921_CR21","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.1021\/ac301243k","volume":"84","author":"C Ib\u00e1\u00f1ez","year":"2012","unstructured":"Ib\u00e1\u00f1ez, C. et al. Toward a predictive model of Alzheimer\u2019s disease progression using capillary electrophoresis-mass spectrometry metabolomics. Anal. Chem. 84, 8532\u20138540 (2012).","journal-title":"Anal. Chem."},{"key":"77921_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1515\/tnsci-2018-0009","volume":"9","author":"G Fonar","year":"2018","unstructured":"Fonar, G. et al. Intracerebroventricular administration of L-arginine improves spatial memory acquisition in triple transgenic mice via reduction of oxidative stress and apoptosis. Transl. Neurosci. 9, 43\u201353 (2018).","journal-title":"Transl. Neurosci."},{"key":"77921_CR23","doi-asserted-by":"publisher","first-page":"135254","DOI":"10.1016\/j.molstruc.2023.135254","volume":"1282","author":"\u0130 Sar\u0131","year":"2023","unstructured":"Sar\u0131, \u0130. et al. Changes in arginine metabolism in advanced Alzheimer\u2019s patients: Experimental and theoretical analyses. J. Mol. Struct. 1282, 135254 (2023).","journal-title":"J. Mol. Struct."},{"key":"77921_CR24","doi-asserted-by":"publisher","first-page":"176030","DOI":"10.1016\/j.ejphar.2023.176030","volume":"958","author":"S Geravand","year":"2023","unstructured":"Geravand, S., Karami, M., Sahraei, H. & Rahimi, F. Protective effects of L-arginine on Alzheimer\u2019s disease: Modulating hippocampal nitric oxide levels and memory deficits in aluminum chloride-induced rat model. Eur. J. Pharmacol. 958, 176030 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"77921_CR25","doi-asserted-by":"publisher","first-page":"102139","DOI":"10.1016\/j.arr.2023.102139","volume":"92","author":"A Zinellu","year":"2023","unstructured":"Zinellu, A., Tommasi, S., Sedda, S. & Mangoni, A. A. Circulating arginine metabolites in Alzheimer\u2019s disease and vascular dementia: A systematic review and meta-analysis. Ageing Res. Rev. 92, 102139 (2023).","journal-title":"Ageing Res. Rev."},{"key":"77921_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/toxins9030092","volume":"9","author":"Y Tain","year":"2017","unstructured":"Tain, Y. & Hsu, C. Toxic dimethylarginines: Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Toxins. 9, 92 (2017).","journal-title":"Toxins"},{"key":"77921_CR27","doi-asserted-by":"publisher","first-page":"1183586","DOI":"10.3389\/fendo.2023.1183586","volume":"14","author":"X Guo","year":"2023","unstructured":"Guo, X., Xing, Y. & Jin, W. Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus. Front. Endocrinol. 14, 1183586 (2023).","journal-title":"Front. Endocrinol."},{"key":"77921_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2016.07.074","volume":"478","author":"IK Cheah","year":"2016","unstructured":"Cheah, I. K., Feng, L., Tang, R. M. Y., Lim, K. H. C. & Halliwell, B. Ergothioneine levels in an elderly population decrease with age and incidence of cognitive decline; a risk factor for neurodegeneration? Biochem. Biophys. Res. Commun. 478, 162\u2013167 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"77921_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.freeradbiomed.2021.10.019","volume":"177","author":"LY Wu","year":"2021","unstructured":"Wu, L. Y. et al. Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia. Free Radic. Biol. Med. 177, 201\u2013211 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"77921_CR30","doi-asserted-by":"publisher","first-page":"1107436","DOI":"10.3389\/fnins.2023.1107436","volume":"17","author":"P Wijesinghe","year":"2023","unstructured":"Wijesinghe, P. et al. Ergothioneine, a dietary antioxidant improves amyloid beta clearance in the neuroretina of a mouse model of Alzheimer\u2019s disease. Front. Neurosci. 17, 1107436 (2023).","journal-title":"Front. Neurosci."},{"key":"77921_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1615\/IntJMedMushrooms.2020033766","volume":"22","author":"CH Liang","year":"2020","unstructured":"Liang, C. H., Huang, P. C., Mau, J. L. & Chiang, S. S. Effect of the king oyster culinary-medicinal mushroom Pleurotus eryngii (Agaricomycetes) basidiocarps powder to ameliorate memory and learning deficit in ability in A\u03b2-induced Alzheimer\u2019s disease C57BL\/6J mice model. Int. J. Med. Mushrooms. 22, 145\u2013159 (2020).","journal-title":"Int. J. Med. Mushrooms"},{"key":"77921_CR32","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3109\/10715762.2014.920954","volume":"48","author":"TY Song","year":"2014","unstructured":"Song, T. Y. et al. Ergothioneine and melatonin attenuate oxidative stress and protect against learning and memory deficits in C57BL\/6J mice treated with D-galactose. Free Radic. Res. 48, 1049\u20131060 (2014).","journal-title":"Free Radic. Res."},{"key":"77921_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/1874467213666200212102710","volume":"14","author":"N Nakamichi","year":"2020","unstructured":"Nakamichi, N. et al. Oral administration of the food-derived hydrophilic antioxidant ergothioneine enhances object recognition memory in mice. Curr. Mol. Pharmacol. 14, 220\u2013233 (2020).","journal-title":"Curr. Mol. Pharmacol."},{"key":"77921_CR34","doi-asserted-by":"crossref","unstructured":"Teruya, T., Chen, Y. J., Kondoh, H., Fukuji, Y. & Yanagida, M. Whole-blood metabolomics of dementia patients reveal classes of disease-linked metabolites. Proc. Natl. Acad. Sci. 118, e2022857118 (2021).","DOI":"10.1073\/pnas.2022857118"},{"key":"77921_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17219\/pim\/145512","volume":"52","author":"M Imran","year":"2022","unstructured":"Imran, M., Samal, M., Qadir, D. A., Ali, A. & Mir, S. R. A critical review on the extraction and pharmacotherapeutic activity of piperine. Polym. Med. 52, 31\u201336 (2022).","journal-title":"Polym. Med."},{"key":"77921_CR36","doi-asserted-by":"publisher","first-page":"108261","DOI":"10.1016\/j.jnutbio.2019.108261","volume":"75","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Piperine regulates glycogen synthase kinase-3\u03b2-related signaling and attenuates cognitive decline in D-galactose-induced aging mouse model. J. Nutr. Biochem. 75, 108261 (2020).","journal-title":"J. Nutr. Biochem."},{"key":"77921_CR37","doi-asserted-by":"publisher","first-page":"595471","DOI":"10.3389\/fphar.2020.595471","volume":"11","author":"S Kumar","year":"2021","unstructured":"Kumar, S. et al. Downregulation of candidate gene expression and neuroprotection by piperine in Streptozotocin-induced hyperglycemia and memory impairment in rats. Front. Pharmacol. 11, 595471 (2021).","journal-title":"Front. Pharmacol."},{"key":"77921_CR38","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.scitotenv.2017.07.258","volume":"609","author":"E Gracia-Lor","year":"2017","unstructured":"Gracia-Lor, E. et al. Estimation of caffeine intake from analysis of caffeine metabolites in wastewater. Sci. Total Environ. 609, 1582\u20131588 (2017).","journal-title":"Sci. Total Environ."},{"key":"77921_CR39","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1111\/j.1750-3841.2010.01561.x","volume":"75","author":"MA Heckman","year":"2010","unstructured":"Heckman, M. A., Weil, J. & De Mejia, E. G. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J. Food Sci. 75, R77\u2013R87 (2010).","journal-title":"J. Food Sci."},{"key":"77921_CR40","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.3390\/molecules27123737","volume":"27","author":"M Yelanchezian","year":"2022","unstructured":"Yelanchezian, M. et al. Neuroprotective effect of caffeine in Alzheimer\u2019s disease. Molecules. 27, 3737 (2022).","journal-title":"Molecules"},{"key":"77921_CR41","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/nu14091697","volume":"14","author":"SC Larsson","year":"2022","unstructured":"Larsson, S. C., Woolf, B. & Gill, D. Plasma caffeine levels and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: Mendelian randomization study. Nutrients. 14, 1697 (2022).","journal-title":"Nutrients"},{"key":"77921_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","volume":"100","author":"F Yin","year":"2016","unstructured":"Yin, F., Sancheti, H., Patil, I. & Cadenas, E. Energy metabolism and inflammation in brain aging and Alzheimer\u2019s disease. Free Radic. Biol. Med. 100, 108\u2013122 (2016).","journal-title":"Free Radic Biol. Med."},{"key":"77921_CR43","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai, R., Guo, J., Ye, X. Y., Xie, Y. & Xie, T. Oxidative stress: The core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res. Rev. 77, 101619 (2022).","journal-title":"Ageing Res. Rev."},{"key":"77921_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell. Biol. 19, 121\u2013135 (2018).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"77921_CR45","doi-asserted-by":"publisher","first-page":"114174","DOI":"10.1016\/j.bcp.2020.114174","volume":"180","author":"MP Srinivasan","year":"2020","unstructured":"Srinivasan, M. P. et al. Activation of AMP-activated protein kinase attenuates ethanol-induced ER\/oxidative stress and lipid phenotype in human pancreatic acinar cells. Biochem. Pharmacol. 180, 114174 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"77921_CR46","doi-asserted-by":"publisher","first-page":"118156","DOI":"10.1016\/j.lfs.2020.118156","volume":"258","author":"X Zhong","year":"2020","unstructured":"Zhong, X. et al. Flavin adenine dinucleotide ameliorates hypertensive vascular remodeling via activating short chain acyl-CoA dehydrogenase. Life Sci. 258, 118156 (2020).","journal-title":"Life Sci."},{"key":"77921_CR47","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.3390\/nu13093229","volume":"13","author":"K Stach","year":"2021","unstructured":"Stach, K., Stach, W. & Augoff, K. Vitamin B6 in health and disease. Nutrients. 13, 3229 (2021).","journal-title":"Nutrients"},{"key":"77921_CR48","first-page":"e12525","volume":"16","author":"AG Przybelski","year":"2024","unstructured":"Przybelski, A. G., Bendlin, B. B., Jones, J. E., Vogt, N. M. & Przybelski, R. J. Vitamin B6 and vitamin D deficiency co-occurrence in geriatric memory patients. Alzheimers Dement. Diagn. Assess. Dis. Monit. 16, e12525 (2024).","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"77921_CR49","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tips.2011.05.003","volume":"32","author":"JM Zhuo","year":"2011","unstructured":"Zhuo, J. M., Wang, H. & Pratic\u00f2, D. Is hyperhomocysteinemia an Alzheimer\u2019s disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol. Sci. 32, 562\u2013571 (2011).","journal-title":"Trends Pharmacol. Sci."},{"key":"77921_CR50","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/1533317506289282","volume":"21","author":"S Annerbo","year":"2006","unstructured":"Annerbo, S., Wahlund, L. O. & L\u00f6kk, J. The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer\u2019s disease in mild cognitive impairment: a 6-year follow-up study. Am. J. Alzheimers Dis. Dementiasr. 21, 182\u2013188 (2006).","journal-title":"Am. J. Alzheimers Dis. Dementiasr."},{"key":"77921_CR51","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri, S. et al. Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N. Engl. J. Med. 346, 476\u2013483 (2002).","journal-title":"N. Engl. J. Med."},{"key":"77921_CR52","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3233\/JAD-150977","volume":"52","author":"Q Hu","year":"2016","unstructured":"Hu, Q., Teng, W., Li, J., Hao, F. & Wang, N. Homocysteine and Alzheimer\u2019s disease: Evidence for a causal link from Mendelian randomization. J. Alzheimers Dis. 52, 747\u2013756 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"77921_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo, A., Das, S. & Hyman, B. T. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 20, 68\u201380 (2021).","journal-title":"Lancet Neurol."},{"key":"77921_CR54","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens, Y. A. et al. ApoE cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron. 110, 1304\u20131317 (2022).","journal-title":"Neuron"},{"key":"77921_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","volume":"17","author":"N Koutsodendris","year":"2022","unstructured":"Koutsodendris, N., Nelson, M. R., Rao, A. & Huang, Y. Apolipoprotein E and Alzheimer\u2019s disease: Findings, hypotheses, and potential mechanisms. Annu. Rev. Pathol. Mech. Dis. 17, 73\u201399 (2022).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"77921_CR56","doi-asserted-by":"publisher","first-page":"108572","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi, G. et al. ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism. Cell. Rep. 34, 108572 (2021).","journal-title":"Cell. Rep."},{"key":"77921_CR57","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jalz.2016.08.003","volume":"13","author":"P Proitsi","year":"2017","unstructured":"Proitsi, P. et al. Association of blood lipids with alzheimer\u2019s disease: A comprehensive lipidomics analysis. Alzheimers Dement. J. Alzheimers Assoc. 13, 140\u2013151 (2017).","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"77921_CR58","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-food-111317-095850","volume":"9","author":"F Shahidi","year":"2018","unstructured":"Shahidi, F. & Ambigaipalan, P. Omega-3 polyunsaturated fatty acids and their health benefits. Annu. Rev. Food Sci. Technol. 9, 345\u2013381 (2018).","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"77921_CR59","doi-asserted-by":"publisher","first-page":"e2053","DOI":"10.1212\/WNL.0000000000008464","volume":"93","author":"T Honda","year":"2019","unstructured":"Honda, T. et al. Serum elaidic acid concentration and risk of dementia: The Hisayama study. Neurology. 93, e2053\u2013e2064 (2019).","journal-title":"Neurology"},{"key":"77921_CR60","doi-asserted-by":"publisher","first-page":"e2426872","DOI":"10.1001\/jamanetworkopen.2024.26872","volume":"7","author":"LH Shinto","year":"2024","unstructured":"Shinto, L. H. et al. \u03c9-3 PUFA for secondary prevention of white matter lesions and neuronal integrity breakdown in older adults: A randomized clinical trial. JAMA Netw. Open. 7, e2426872 (2024).","journal-title":"JAMA Netw. Open"},{"key":"77921_CR61","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/ijms24043754","volume":"24","author":"J Andrade-Guerrero","year":"2023","unstructured":"Andrade-Guerrero, J. et al. Alzheimer\u2019s disease: An updated overview of its genetics. Int. J. Mol. Sci. 24, 3754 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"77921_CR62","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1080\/15548627.2019.1596489","volume":"15","author":"C Fedeli","year":"2019","unstructured":"Fedeli, C., Filadi, R., Rossi, A., Mammucari, C. & Pizzo, P. PSEN2 (presenilin 2) mutants linked to familial Alzheimer disease impair autophagy by altering Ca2\u2009+\u2009homeostasis. Autophagy. 15, 2044\u20132062 (2019).","journal-title":"Autophagy"},{"key":"77921_CR63","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe, C., Van Broeckhoven, C. & Sleegers, K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet. Med. 18, 421\u2013430 (2016).","journal-title":"Genet. Med."},{"key":"77921_CR64","doi-asserted-by":"publisher","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. HMDB 4.0: The human metabolome database for 2018. Nucleic Acids Res. 46, D608\u2013D617 (2018).","journal-title":"Nucleic Acids Res."},{"key":"77921_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"77921_CR66","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"77921_CR67","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"key":"77921_CR68","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess, S., Bowden, J., Fall, T., Ingelsson, E. & Thompson, S. G. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology.  28, 30\u201342 (2017).","journal-title":"Epidemiology"},{"key":"77921_CR69","doi-asserted-by":"publisher","first-page":"1121273","DOI":"10.3389\/fimmu.2023.1121273","volume":"14","author":"Q Jin","year":"2023","unstructured":"Jin, Q. et al. The causality between intestinal flora and allergic diseases: Insights from a bi-directional two-sample Mendelian randomization analysis. Front. Immunol. 14, 1121273 (2023).","journal-title":"Front. Immunol."},{"key":"77921_CR70","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13059-020-02113-0","volume":"21","author":"NR Gay","year":"2020","unstructured":"Gay, N. R. et al. Impact of admixture and ancestry on eQTL analysis and GWAS colocalization in GTEx. Genome Biol. 21, 233 (2020).","journal-title":"Genome Biol."},{"key":"77921_CR71","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).","journal-title":"PLoS Genet."},{"key":"77921_CR72","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","volume":"109","author":"V Zuber","year":"2022","unstructured":"Zuber, V. et al. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. Am. J. Hum. Genet. 109, 767\u2013782 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"77921_CR73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson, T. et al. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature. 488, 96\u201399 (2012).","journal-title":"Nature"},{"key":"77921_CR74","doi-asserted-by":"publisher","first-page":"108615","DOI":"10.1016\/j.celrep.2020.108615","volume":"34","author":"C Arber","year":"2021","unstructured":"Arber, C. et al. Familial Alzheimer\u2019s disease mutations in PSEN1 lead to premature human stem cell neurogenesis. Cell. Rep. 34, 108615 (2021).","journal-title":"Cell. Rep."},{"key":"77921_CR75","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace, R., Sleegers, K. & Van Broeckhoven, C. Molecular genetics of early-onset Alzheimer\u2019s disease revisited. Alzheimers Dement. 12, 733\u2013748 (2016).","journal-title":"Alzheimers Dement."},{"key":"77921_CR76","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-021-00773-z","volume":"13","author":"The VA Million Veteran Program","year":"2021","unstructured":"The VA Million Veteran Program. Multi-trait association studies discover pleiotropic loci between Alzheimer\u2019s disease and cardiometabolic traits. Alzheimers Res. Ther. 13, 34 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"77921_CR77","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/s41588-018-0255-0","volume":"50","author":"LJ O\u2019Connor","year":"2018","unstructured":"O\u2019Connor, L. J. & Price, A. L. Distinguishing genetic correlation from causation across 52 diseases and complex traits. Nat. Genet. 50, 1728\u20131734 (2018).","journal-title":"Nat. Genet."},{"key":"77921_CR78","doi-asserted-by":"publisher","first-page":"eabj8969","DOI":"10.1126\/sciadv.abj8969","volume":"8","author":"WR Reay","year":"2022","unstructured":"Reay, W. R. et al. Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders. Sci. Adv. 8, eabj8969 (2022).","journal-title":"Sci. Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77921-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77921-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77921-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:10:05Z","timestamp":1730297405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77921-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77921"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77921-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"In conducting this research, we focused on data that is publicly accessible and has received approval from the appropriate review boards. Each contributing study to our analysis was cleared by the respective country\u2019s institutional review board, aligning with the guidelines of the Declaration of Helsinki. The data involved in this study were obtained from publicly published and ethically approved GWAS studies, which were all provided with written informed consent. There was no direct interaction with patients in this study, eliminating the need for further ethical approval. This study was strictly conducted following the STROBE-MR guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"26078"}}